MTT assays and colony formation assays suggested that gemcitabine significantly restrained the proliferation of pancreatic cancer cells, and overexpression of ANRIL resisted the inhibitory effects of gemcitabine. The gene discussed is CDKN2B-AS1; the disease is familial pancreatic carcinoma.